nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Topotecan—lung cancer	0.0724	0.142	CbGbCtD
Desvenlafaxine—CYP3A4—Gefitinib—lung cancer	0.0662	0.13	CbGbCtD
Desvenlafaxine—CYP3A4—Teniposide—lung cancer	0.0642	0.126	CbGbCtD
Desvenlafaxine—CYP3A4—Vinorelbine—lung cancer	0.051	0.1	CbGbCtD
Desvenlafaxine—CYP3A4—Crizotinib—lung cancer	0.0406	0.0796	CbGbCtD
Desvenlafaxine—CYP3A4—Erlotinib—lung cancer	0.0391	0.0768	CbGbCtD
Desvenlafaxine—CYP3A4—Paclitaxel—lung cancer	0.0358	0.0703	CbGbCtD
Desvenlafaxine—CYP3A4—Irinotecan—lung cancer	0.0353	0.0694	CbGbCtD
Desvenlafaxine—CYP3A4—Vinblastine—lung cancer	0.0314	0.0617	CbGbCtD
Desvenlafaxine—CYP3A4—Etoposide—lung cancer	0.0283	0.0556	CbGbCtD
Desvenlafaxine—CYP3A4—Docetaxel—lung cancer	0.0259	0.0508	CbGbCtD
Desvenlafaxine—CYP3A4—Doxorubicin—lung cancer	0.0193	0.0379	CbGbCtD
Desvenlafaxine—Venlafaxine—ABCG2—lung cancer	0.00408	0.706	CrCbGaD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—SYP—lung cancer	0.00265	0.0443	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Felbamate Metabolism—CYP2E1—lung cancer	0.00263	0.0439	CbGpPWpGaD
Desvenlafaxine—Venlafaxine—ABCB1—lung cancer	0.0017	0.294	CrCbGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.00133	0.0222	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—lung cancer	0.00125	0.0209	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—lung cancer	0.00117	0.0196	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00111	0.0186	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—PRDX1—lung cancer	0.000866	0.0145	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.000842	0.0141	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTM2—lung cancer	0.000814	0.0136	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.000798	0.0134	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—PRDX1—lung cancer	0.000744	0.0125	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.00073	0.0122	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000727	0.0122	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.000702	0.0118	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTM2—lung cancer	0.0007	0.0117	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.000692	0.0116	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.000676	0.0113	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—KMT2A—lung cancer	0.00067	0.0112	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.000669	0.0112	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000666	0.0111	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTA3—lung cancer	0.000656	0.011	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.000653	0.0109	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—KEAP1—lung cancer	0.000617	0.0103	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TOP1—lung cancer	0.000613	0.0103	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTA4—lung cancer	0.0006	0.01	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NKX2-1—lung cancer	0.000598	0.01	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000585	0.00979	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTA2—lung cancer	0.000585	0.00978	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000566	0.00947	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTA1—lung cancer	0.000564	0.00944	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTA3—lung cancer	0.000564	0.00944	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—ABCC3—lung cancer	0.000558	0.00933	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.000547	0.00916	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—KEAP1—lung cancer	0.00053	0.00888	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—UGT1A1—lung cancer	0.000525	0.00878	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTA4—lung cancer	0.000516	0.00863	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.000507	0.00849	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000505	0.00844	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTA2—lung cancer	0.000503	0.00841	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000497	0.00832	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—NFE2L2—lung cancer	0.000497	0.00832	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000489	0.00819	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTA1—lung cancer	0.000485	0.00812	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—ABCC3—lung cancer	0.00048	0.00803	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFA—lung cancer	0.000474	0.00794	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000472	0.00789	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000471	0.00787	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000459	0.00769	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.000457	0.00764	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—UGT1A1—lung cancer	0.000451	0.00755	CbGpPWpGaD
Desvenlafaxine—Cardiac disorder—Docetaxel—lung cancer	0.000449	0.00106	CcSEcCtD
Desvenlafaxine—Vomiting—Topotecan—lung cancer	0.000448	0.00105	CcSEcCtD
Desvenlafaxine—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000448	0.00749	CbGpPWpGaD
Desvenlafaxine—Paraesthesia—Irinotecan—lung cancer	0.000447	0.00105	CcSEcCtD
Desvenlafaxine—Vertigo—Paclitaxel—lung cancer	0.000447	0.00105	CcSEcCtD
Desvenlafaxine—Syncope—Paclitaxel—lung cancer	0.000446	0.00105	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Etoposide—lung cancer	0.000446	0.00105	CcSEcCtD
Desvenlafaxine—Rash—Topotecan—lung cancer	0.000445	0.00105	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Vinorelbine—lung cancer	0.000444	0.00105	CcSEcCtD
Desvenlafaxine—Dermatitis—Topotecan—lung cancer	0.000444	0.00104	CcSEcCtD
Desvenlafaxine—Vomiting—Erlotinib—lung cancer	0.000444	0.00104	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Cisplatin—lung cancer	0.000443	0.00104	CcSEcCtD
Desvenlafaxine—Somnolence—Irinotecan—lung cancer	0.000442	0.00104	CcSEcCtD
Desvenlafaxine—Headache—Topotecan—lung cancer	0.000442	0.00104	CcSEcCtD
Desvenlafaxine—Tachycardia—Cisplatin—lung cancer	0.000441	0.00104	CcSEcCtD
Desvenlafaxine—Rash—Erlotinib—lung cancer	0.00044	0.00103	CcSEcCtD
Desvenlafaxine—Dermatitis—Erlotinib—lung cancer	0.000439	0.00103	CcSEcCtD
Desvenlafaxine—Palpitations—Paclitaxel—lung cancer	0.000439	0.00103	CcSEcCtD
Desvenlafaxine—Convulsion—Etoposide—lung cancer	0.000439	0.00103	CcSEcCtD
Desvenlafaxine—Angiopathy—Docetaxel—lung cancer	0.000439	0.00103	CcSEcCtD
Desvenlafaxine—Skin disorder—Cisplatin—lung cancer	0.000439	0.00103	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Doxorubicin—lung cancer	0.000438	0.00103	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000438	0.00733	CbGpPWpGaD
Desvenlafaxine—Insomnia—Gemcitabine—lung cancer	0.000438	0.00103	CcSEcCtD
Desvenlafaxine—Hypertension—Etoposide—lung cancer	0.000438	0.00103	CcSEcCtD
Desvenlafaxine—Immune system disorder—Docetaxel—lung cancer	0.000437	0.00103	CcSEcCtD
Desvenlafaxine—Headache—Erlotinib—lung cancer	0.000437	0.00103	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Paclitaxel—lung cancer	0.000437	0.00103	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000437	0.00103	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Cisplatin—lung cancer	0.000437	0.00103	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Docetaxel—lung cancer	0.000436	0.00103	CcSEcCtD
Desvenlafaxine—Paraesthesia—Gemcitabine—lung cancer	0.000435	0.00102	CcSEcCtD
Desvenlafaxine—Chills—Docetaxel—lung cancer	0.000434	0.00102	CcSEcCtD
Desvenlafaxine—Asthenia—Vinorelbine—lung cancer	0.000433	0.00102	CcSEcCtD
Desvenlafaxine—Decreased appetite—Irinotecan—lung cancer	0.000432	0.00102	CcSEcCtD
Desvenlafaxine—Nausea—Vinblastine—lung cancer	0.000431	0.00101	CcSEcCtD
Desvenlafaxine—Somnolence—Gemcitabine—lung cancer	0.000431	0.00101	CcSEcCtD
Desvenlafaxine—Convulsion—Paclitaxel—lung cancer	0.000431	0.00101	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000429	0.00101	CcSEcCtD
Desvenlafaxine—Hypertension—Paclitaxel—lung cancer	0.000429	0.00101	CcSEcCtD
Desvenlafaxine—Fatigue—Irinotecan—lung cancer	0.000429	0.00101	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000429	0.00101	CcSEcCtD
Desvenlafaxine—Alopecia—Docetaxel—lung cancer	0.000428	0.00101	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—GCLC—lung cancer	0.000428	0.00715	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—CYP2A6—lung cancer	0.000428	0.00715	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—NFE2L2—lung cancer	0.000428	0.00715	CbGpPWpGaD
Desvenlafaxine—Constipation—Irinotecan—lung cancer	0.000425	0.001	CcSEcCtD
Desvenlafaxine—Mental disorder—Docetaxel—lung cancer	0.000424	0.000998	CcSEcCtD
Desvenlafaxine—Anxiety—Paclitaxel—lung cancer	0.000422	0.000992	CcSEcCtD
Desvenlafaxine—Malnutrition—Docetaxel—lung cancer	0.000421	0.000991	CcSEcCtD
Desvenlafaxine—Decreased appetite—Gemcitabine—lung cancer	0.000421	0.000991	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.00042	0.000989	CcSEcCtD
Desvenlafaxine—Nausea—Topotecan—lung cancer	0.000419	0.000985	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000418	0.000984	CcSEcCtD
Desvenlafaxine—Fatigue—Gemcitabine—lung cancer	0.000418	0.000983	CcSEcCtD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000418	0.00699	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000416	0.00696	CbGpPWpGaD
Desvenlafaxine—Constipation—Gemcitabine—lung cancer	0.000414	0.000975	CcSEcCtD
Desvenlafaxine—Nausea—Erlotinib—lung cancer	0.000414	0.000975	CcSEcCtD
Desvenlafaxine—Dry mouth—Paclitaxel—lung cancer	0.000414	0.000974	CcSEcCtD
Desvenlafaxine—Diarrhoea—Vinorelbine—lung cancer	0.000413	0.000971	CcSEcCtD
Desvenlafaxine—Dysgeusia—Docetaxel—lung cancer	0.000413	0.000971	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000412	0.0069	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFA—lung cancer	0.000408	0.00682	CbGpPWpGaD
Desvenlafaxine—Paraesthesia—Cisplatin—lung cancer	0.000406	0.000954	CcSEcCtD
Desvenlafaxine—Tachycardia—Etoposide—lung cancer	0.000404	0.00095	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Doxorubicin—lung cancer	0.000403	0.000948	CcSEcCtD
Desvenlafaxine—Skin disorder—Etoposide—lung cancer	0.000402	0.000946	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Methotrexate—lung cancer	0.000401	0.000944	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TF—lung cancer	0.000401	0.00671	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.0004	0.00669	CbGpPWpGaD
Desvenlafaxine—Hyperhidrosis—Etoposide—lung cancer	0.0004	0.000941	CcSEcCtD
Desvenlafaxine—Shock—Paclitaxel—lung cancer	0.000399	0.000939	CcSEcCtD
Desvenlafaxine—Dizziness—Vinorelbine—lung cancer	0.000399	0.000938	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000399	0.000938	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Paclitaxel—lung cancer	0.000398	0.000936	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Methotrexate—lung cancer	0.000398	0.000936	CcSEcCtD
Desvenlafaxine—Tachycardia—Paclitaxel—lung cancer	0.000396	0.000932	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—AHR—lung cancer	0.000395	0.00661	CbGpPWpGaD
Desvenlafaxine—Breast disorder—Doxorubicin—lung cancer	0.000395	0.000928	CcSEcCtD
Desvenlafaxine—Skin disorder—Paclitaxel—lung cancer	0.000394	0.000927	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000393	0.000925	CcSEcCtD
Desvenlafaxine—Decreased appetite—Cisplatin—lung cancer	0.000393	0.000924	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Paclitaxel—lung cancer	0.000392	0.000923	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Cisplatin—lung cancer	0.00039	0.000917	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000385	0.000906	CcSEcCtD
Desvenlafaxine—Vomiting—Vinorelbine—lung cancer	0.000383	0.000902	CcSEcCtD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000382	0.00639	CbGpPWpGaD
Desvenlafaxine—Rash—Vinorelbine—lung cancer	0.00038	0.000895	CcSEcCtD
Desvenlafaxine—Dermatitis—Vinorelbine—lung cancer	0.00038	0.000894	CcSEcCtD
Desvenlafaxine—Headache—Vinorelbine—lung cancer	0.000378	0.000889	CcSEcCtD
Desvenlafaxine—Syncope—Docetaxel—lung cancer	0.000378	0.000889	CcSEcCtD
Desvenlafaxine—Palpitations—Docetaxel—lung cancer	0.000372	0.000876	CcSEcCtD
Desvenlafaxine—Paraesthesia—Etoposide—lung cancer	0.000372	0.000874	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Docetaxel—lung cancer	0.00037	0.000871	CcSEcCtD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.00037	0.00619	CbGpPWpGaD
Desvenlafaxine—Somnolence—Etoposide—lung cancer	0.000368	0.000865	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—GCLC—lung cancer	0.000368	0.00615	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—CYP2A6—lung cancer	0.000368	0.00615	CbGpPWpGaD
Desvenlafaxine—Insomnia—Paclitaxel—lung cancer	0.000367	0.000863	CcSEcCtD
Desvenlafaxine—Epistaxis—Methotrexate—lung cancer	0.000367	0.000862	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Irinotecan—lung cancer	0.000366	0.000862	CcSEcCtD
Desvenlafaxine—Convulsion—Docetaxel—lung cancer	0.000365	0.000859	CcSEcCtD
Desvenlafaxine—Paraesthesia—Paclitaxel—lung cancer	0.000364	0.000857	CcSEcCtD
Desvenlafaxine—Hypertension—Docetaxel—lung cancer	0.000364	0.000856	CcSEcCtD
Desvenlafaxine—Somnolence—Paclitaxel—lung cancer	0.000361	0.000849	CcSEcCtD
Desvenlafaxine—Decreased appetite—Etoposide—lung cancer	0.00036	0.000846	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—NQO1—lung cancer	0.00036	0.00601	CbGpPWpGaD
Desvenlafaxine—Nausea—Vinorelbine—lung cancer	0.000358	0.000843	CcSEcCtD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000357	0.00598	CbGpPWpGaD
Desvenlafaxine—Gastrointestinal disorder—Etoposide—lung cancer	0.000357	0.00084	CcSEcCtD
Desvenlafaxine—Asthenia—Irinotecan—lung cancer	0.000357	0.00084	CcSEcCtD
Desvenlafaxine—Fatigue—Etoposide—lung cancer	0.000357	0.000839	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000356	0.000838	CcSEcCtD
Desvenlafaxine—Constipation—Etoposide—lung cancer	0.000354	0.000832	CcSEcCtD
Desvenlafaxine—Decreased appetite—Paclitaxel—lung cancer	0.000353	0.00083	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—ADCY1—lung cancer	0.000352	0.00589	CbGpPWpGaD
Desvenlafaxine—Dry mouth—Docetaxel—lung cancer	0.000351	0.000825	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00035	0.000824	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.00035	0.00585	CbGpPWpGaD
Desvenlafaxine—Fatigue—Paclitaxel—lung cancer	0.00035	0.000823	CcSEcCtD
Desvenlafaxine—Asthenia—Gemcitabine—lung cancer	0.000348	0.000818	CcSEcCtD
Desvenlafaxine—Constipation—Paclitaxel—lung cancer	0.000347	0.000816	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000345	0.00578	CbGpPWpGaD
Desvenlafaxine—Urinary tract disorder—Methotrexate—lung cancer	0.000345	0.000811	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000344	0.00081	CcSEcCtD
Desvenlafaxine—Weight increased—Doxorubicin—lung cancer	0.000343	0.000808	CcSEcCtD
Desvenlafaxine—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000343	0.00574	CbGpPWpGaD
Desvenlafaxine—Urethral disorder—Methotrexate—lung cancer	0.000342	0.000805	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—lung cancer	0.000341	0.000803	CcSEcCtD
Desvenlafaxine—Diarrhoea—Irinotecan—lung cancer	0.00034	0.000801	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000338	0.00566	CbGpPWpGaD
Desvenlafaxine—Shock—Docetaxel—lung cancer	0.000338	0.000796	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Docetaxel—lung cancer	0.000337	0.000793	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000336	0.00562	CbGpPWpGaD
Desvenlafaxine—Tachycardia—Docetaxel—lung cancer	0.000336	0.00079	CcSEcCtD
Desvenlafaxine—Skin disorder—Docetaxel—lung cancer	0.000334	0.000786	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000334	0.000785	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Cisplatin—lung cancer	0.000333	0.000783	CcSEcCtD
Desvenlafaxine—Diarrhoea—Gemcitabine—lung cancer	0.000332	0.00078	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Methotrexate—lung cancer	0.00033	0.000776	CcSEcCtD
Desvenlafaxine—Dizziness—Irinotecan—lung cancer	0.000329	0.000774	CcSEcCtD
Desvenlafaxine—Eye disorder—Methotrexate—lung cancer	0.000326	0.000767	CcSEcCtD
Desvenlafaxine—Tinnitus—Methotrexate—lung cancer	0.000325	0.000765	CcSEcCtD
Desvenlafaxine—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000325	0.00544	CbGpPWpGaD
Desvenlafaxine—Asthenia—Cisplatin—lung cancer	0.000324	0.000762	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methotrexate—lung cancer	0.000324	0.000762	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—lung cancer	0.000317	0.000747	CcSEcCtD
Desvenlafaxine—Angiopathy—Methotrexate—lung cancer	0.000317	0.000745	CcSEcCtD
Desvenlafaxine—Vomiting—Irinotecan—lung cancer	0.000316	0.000744	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methotrexate—lung cancer	0.000315	0.000741	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methotrexate—lung cancer	0.000314	0.00074	CcSEcCtD
Desvenlafaxine—Rash—Irinotecan—lung cancer	0.000314	0.000738	CcSEcCtD
Desvenlafaxine—Dermatitis—Irinotecan—lung cancer	0.000313	0.000737	CcSEcCtD
Desvenlafaxine—Chills—Methotrexate—lung cancer	0.000313	0.000736	CcSEcCtD
Desvenlafaxine—Headache—Irinotecan—lung cancer	0.000312	0.000733	CcSEcCtD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000311	0.00521	CbGpPWpGaD
Desvenlafaxine—Insomnia—Docetaxel—lung cancer	0.000311	0.000732	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—NQO1—lung cancer	0.000309	0.00517	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Cisplatin—lung cancer	0.000309	0.000727	CcSEcCtD
Desvenlafaxine—Paraesthesia—Docetaxel—lung cancer	0.000309	0.000726	CcSEcCtD
Desvenlafaxine—Alopecia—Methotrexate—lung cancer	0.000308	0.000725	CcSEcCtD
Desvenlafaxine—Vomiting—Gemcitabine—lung cancer	0.000308	0.000725	CcSEcCtD
Desvenlafaxine—Somnolence—Docetaxel—lung cancer	0.000306	0.000719	CcSEcCtD
Desvenlafaxine—Mental disorder—Methotrexate—lung cancer	0.000306	0.000719	CcSEcCtD
Desvenlafaxine—Rash—Gemcitabine—lung cancer	0.000306	0.000719	CcSEcCtD
Desvenlafaxine—Dermatitis—Gemcitabine—lung cancer	0.000305	0.000718	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Etoposide—lung cancer	0.000305	0.000717	CcSEcCtD
Desvenlafaxine—Malnutrition—Methotrexate—lung cancer	0.000304	0.000714	CcSEcCtD
Desvenlafaxine—Headache—Gemcitabine—lung cancer	0.000304	0.000714	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTP1—lung cancer	0.0003	0.00502	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000299	0.005	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Docetaxel—lung cancer	0.000299	0.000703	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Paclitaxel—lung cancer	0.000299	0.000703	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—lung cancer	0.000298	0.000702	CcSEcCtD
Desvenlafaxine—Dysgeusia—Methotrexate—lung cancer	0.000297	0.0007	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000297	0.000698	CcSEcCtD
Desvenlafaxine—Asthenia—Etoposide—lung cancer	0.000297	0.000698	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—lung cancer	0.000297	0.000698	CcSEcCtD
Desvenlafaxine—Fatigue—Docetaxel—lung cancer	0.000296	0.000698	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—lung cancer	0.000296	0.000697	CcSEcCtD
Desvenlafaxine—Nausea—Irinotecan—lung cancer	0.000295	0.000695	CcSEcCtD
Desvenlafaxine—Constipation—Docetaxel—lung cancer	0.000294	0.000692	CcSEcCtD
Desvenlafaxine—Asthenia—Paclitaxel—lung cancer	0.000291	0.000685	CcSEcCtD
Desvenlafaxine—Nausea—Gemcitabine—lung cancer	0.000288	0.000677	CcSEcCtD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000287	0.00481	CbGpPWpGaD
Desvenlafaxine—Vomiting—Cisplatin—lung cancer	0.000287	0.000676	CcSEcCtD
Desvenlafaxine—Vision blurred—Methotrexate—lung cancer	0.000286	0.000673	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—lung cancer	0.000286	0.000672	CcSEcCtD
Desvenlafaxine—Rash—Cisplatin—lung cancer	0.000285	0.00067	CcSEcCtD
Desvenlafaxine—Dermatitis—Cisplatin—lung cancer	0.000285	0.000669	CcSEcCtD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000284	0.00474	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Etoposide—lung cancer	0.000283	0.000666	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—lung cancer	0.000282	0.000664	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—lung cancer	0.000282	0.000663	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—lung cancer	0.00028	0.00066	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—AVP—lung cancer	0.000278	0.00465	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Paclitaxel—lung cancer	0.000278	0.000653	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTM1—lung cancer	0.000276	0.00461	CbGpPWpGaD
Desvenlafaxine—Angiopathy—Doxorubicin—lung cancer	0.000274	0.000645	CcSEcCtD
Desvenlafaxine—Dizziness—Etoposide—lung cancer	0.000274	0.000644	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—lung cancer	0.000273	0.000642	CcSEcCtD
Desvenlafaxine—Vertigo—Methotrexate—lung cancer	0.000273	0.000642	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—lung cancer	0.000272	0.00064	CcSEcCtD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000272	0.00455	CbGpPWpGaD
Desvenlafaxine—Chills—Doxorubicin—lung cancer	0.000271	0.000638	CcSEcCtD
Desvenlafaxine—Dizziness—Paclitaxel—lung cancer	0.000268	0.000631	CcSEcCtD
Desvenlafaxine—Nausea—Cisplatin—lung cancer	0.000268	0.000631	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—lung cancer	0.000267	0.000628	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—lung cancer	0.000265	0.000623	CcSEcCtD
Desvenlafaxine—Convulsion—Methotrexate—lung cancer	0.000263	0.000619	CcSEcCtD
Desvenlafaxine—Vomiting—Etoposide—lung cancer	0.000263	0.000619	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—lung cancer	0.000263	0.000619	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HES1—lung cancer	0.000263	0.0044	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL10—lung cancer	0.000261	0.00437	CbGpPWpGaD
Desvenlafaxine—Rash—Etoposide—lung cancer	0.000261	0.000614	CcSEcCtD
Desvenlafaxine—Dermatitis—Etoposide—lung cancer	0.000261	0.000613	CcSEcCtD
Desvenlafaxine—Headache—Etoposide—lung cancer	0.000259	0.00061	CcSEcCtD
Desvenlafaxine—Tension—Doxorubicin—lung cancer	0.000258	0.000607	CcSEcCtD
Desvenlafaxine—Vomiting—Paclitaxel—lung cancer	0.000258	0.000607	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTP1—lung cancer	0.000258	0.00431	CbGpPWpGaD
Desvenlafaxine—Dysgeusia—Doxorubicin—lung cancer	0.000258	0.000606	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000257	0.000604	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000256	0.00429	CbGpPWpGaD
Desvenlafaxine—Rash—Paclitaxel—lung cancer	0.000256	0.000602	CcSEcCtD
Desvenlafaxine—Dermatitis—Paclitaxel—lung cancer	0.000256	0.000601	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—lung cancer	0.000255	0.000601	CcSEcCtD
Desvenlafaxine—Headache—Paclitaxel—lung cancer	0.000254	0.000598	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Docetaxel—lung cancer	0.000253	0.000596	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—lung cancer	0.000248	0.000583	CcSEcCtD
Desvenlafaxine—Asthenia—Docetaxel—lung cancer	0.000247	0.00058	CcSEcCtD
Desvenlafaxine—Nausea—Etoposide—lung cancer	0.000246	0.000578	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Methotrexate—lung cancer	0.000243	0.000572	CcSEcCtD
Desvenlafaxine—Nausea—Paclitaxel—lung cancer	0.000241	0.000567	CcSEcCtD
Desvenlafaxine—Skin disorder—Methotrexate—lung cancer	0.000241	0.000566	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Methotrexate—lung cancer	0.00024	0.000564	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTM1—lung cancer	0.000237	0.00396	CbGpPWpGaD
Desvenlafaxine—Vertigo—Doxorubicin—lung cancer	0.000236	0.000556	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—lung cancer	0.000236	0.000555	CcSEcCtD
Desvenlafaxine—Diarrhoea—Docetaxel—lung cancer	0.000235	0.000554	CcSEcCtD
Desvenlafaxine—Palpitations—Doxorubicin—lung cancer	0.000232	0.000547	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—lung cancer	0.000231	0.000544	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—lung cancer	0.000228	0.000536	CcSEcCtD
Desvenlafaxine—Dizziness—Docetaxel—lung cancer	0.000227	0.000535	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—lung cancer	0.000227	0.000534	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—AVP—lung cancer	0.000227	0.0038	CbGpPWpGaD
Desvenlafaxine—Insomnia—Methotrexate—lung cancer	0.000224	0.000527	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—lung cancer	0.000223	0.000525	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000223	0.00373	CbGpPWpGaD
Desvenlafaxine—Paraesthesia—Methotrexate—lung cancer	0.000223	0.000524	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000222	0.000523	CcSEcCtD
Desvenlafaxine—Somnolence—Methotrexate—lung cancer	0.00022	0.000518	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.00022	0.00368	CbGpPWpGaD
Desvenlafaxine—Dry mouth—Doxorubicin—lung cancer	0.000219	0.000515	CcSEcCtD
Desvenlafaxine—Vomiting—Docetaxel—lung cancer	0.000219	0.000514	CcSEcCtD
Desvenlafaxine—Rash—Docetaxel—lung cancer	0.000217	0.00051	CcSEcCtD
Desvenlafaxine—Dermatitis—Docetaxel—lung cancer	0.000217	0.00051	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TYMS—lung cancer	0.000216	0.00361	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Methotrexate—lung cancer	0.000215	0.000507	CcSEcCtD
Desvenlafaxine—Headache—Docetaxel—lung cancer	0.000215	0.000507	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000214	0.000503	CcSEcCtD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000214	0.00358	CbGpPWpGaD
Desvenlafaxine—Fatigue—Methotrexate—lung cancer	0.000214	0.000503	CcSEcCtD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000212	0.00355	CbGpPWpGaD
Desvenlafaxine—Shock—Doxorubicin—lung cancer	0.000211	0.000497	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—lung cancer	0.00021	0.000495	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—lung cancer	0.000209	0.000493	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—lung cancer	0.000208	0.00049	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—lung cancer	0.000207	0.000488	CcSEcCtD
Desvenlafaxine—Nausea—Docetaxel—lung cancer	0.000204	0.000481	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000203	0.0034	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000201	0.00335	CbGpPWpGaD
Desvenlafaxine—Insomnia—Doxorubicin—lung cancer	0.000194	0.000457	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—lung cancer	0.000193	0.000453	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—lung cancer	0.000191	0.000449	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—lung cancer	0.000187	0.000439	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000185	0.000436	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—lung cancer	0.000185	0.000435	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—lung cancer	0.000184	0.000432	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Methotrexate—lung cancer	0.000183	0.00043	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6R—lung cancer	0.00018	0.00301	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.00018	0.00301	CbGpPWpGaD
Desvenlafaxine—Asthenia—Methotrexate—lung cancer	0.000178	0.000418	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000173	0.00289	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000171	0.00287	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000171	0.00285	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Methotrexate—lung cancer	0.00017	0.000399	CcSEcCtD
Desvenlafaxine—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.000167	0.00279	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.000167	0.00279	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000165	0.00276	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000164	0.00275	CbGpPWpGaD
Desvenlafaxine—Dizziness—Methotrexate—lung cancer	0.000164	0.000386	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—AVP—lung cancer	0.000159	0.00266	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Doxorubicin—lung cancer	0.000158	0.000372	CcSEcCtD
Desvenlafaxine—Vomiting—Methotrexate—lung cancer	0.000158	0.000371	CcSEcCtD
Desvenlafaxine—Rash—Methotrexate—lung cancer	0.000156	0.000368	CcSEcCtD
Desvenlafaxine—Dermatitis—Methotrexate—lung cancer	0.000156	0.000367	CcSEcCtD
Desvenlafaxine—Headache—Methotrexate—lung cancer	0.000155	0.000365	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—lung cancer	0.000154	0.000362	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000154	0.00257	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000154	0.00257	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.000151	0.00252	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000149	0.00249	CbGpPWpGaD
Desvenlafaxine—Nausea—Methotrexate—lung cancer	0.000147	0.000346	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—lung cancer	0.000147	0.000345	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000143	0.00239	CbGpPWpGaD
Desvenlafaxine—Dizziness—Doxorubicin—lung cancer	0.000142	0.000334	CcSEcCtD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.00014	0.00234	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000139	0.00233	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000137	0.00229	CbGpPWpGaD
Desvenlafaxine—Vomiting—Doxorubicin—lung cancer	0.000136	0.000321	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—lung cancer	0.000135	0.000318	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—lung cancer	0.000135	0.000318	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—lung cancer	0.000134	0.000316	CcSEcCtD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000134	0.00225	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—JUN—lung cancer	0.000133	0.00222	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000132	0.00222	CbGpPWpGaD
Desvenlafaxine—Nausea—Doxorubicin—lung cancer	0.000127	0.0003	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000125	0.0021	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000125	0.0021	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000124	0.00208	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000123	0.00205	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—EP300—lung cancer	0.000123	0.00205	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000122	0.00205	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000121	0.00203	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.00012	0.002	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TF—lung cancer	0.000116	0.00195	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000116	0.00194	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000115	0.00193	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000109	0.00182	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—JUN—lung cancer	0.000108	0.00181	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000107	0.0018	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000106	0.00177	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PTEN—lung cancer	0.000105	0.00176	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000101	0.00168	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—EP300—lung cancer	0.0001	0.00167	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—lung cancer	9.62e-05	0.00161	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	9.47e-05	0.00158	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	9.25e-05	0.00155	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—HPGDS—lung cancer	9.13e-05	0.00153	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTT1—lung cancer	8.85e-05	0.00148	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GCLC—lung cancer	8.75e-05	0.00146	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2A6—lung cancer	8.75e-05	0.00146	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—AVP—lung cancer	8.07e-05	0.00135	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—lung cancer	8.03e-05	0.00134	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCB1—lung cancer	7.82e-05	0.00131	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	7.5e-05	0.00126	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2E1—lung cancer	7.44e-05	0.00124	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	7.34e-05	0.00123	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TP53—lung cancer	7.16e-05	0.0012	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—IL6—lung cancer	6.55e-05	0.0011	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—APOA1—lung cancer	6.17e-05	0.00103	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTP1—lung cancer	6.14e-05	0.00103	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	6.05e-05	0.00101	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTM1—lung cancer	5.64e-05	0.000943	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	5.56e-05	0.00093	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	5.35e-05	0.000894	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.27e-05	0.000882	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CREBBP—lung cancer	5.22e-05	0.000874	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—lung cancer	4.89e-05	0.000818	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.7e-05	0.000787	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AZIN2—lung cancer	4.7e-05	0.000787	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—RAF1—lung cancer	4.42e-05	0.00074	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ATP5H—lung cancer	4e-05	0.000669	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—POMC—lung cancer	3.99e-05	0.000667	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLBD1—lung cancer	3.56e-05	0.000596	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HSD17B10—lung cancer	3.26e-05	0.000545	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CKB—lung cancer	3.03e-05	0.000507	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CNDP2—lung cancer	2.85e-05	0.000477	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTM2—lung cancer	2.85e-05	0.000477	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTMR3—lung cancer	2.77e-05	0.000464	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PGAM1—lung cancer	2.7e-05	0.000452	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2A7—lung cancer	2.58e-05	0.000431	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SDC4—lung cancer	2.52e-05	0.000422	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA3—lung cancer	2.3e-05	0.000384	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—RRM1—lung cancer	2.3e-05	0.000384	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—B4GALT5—lung cancer	2.16e-05	0.000361	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA4—lung cancer	2.1e-05	0.000351	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA2—lung cancer	2.05e-05	0.000342	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA1—lung cancer	1.97e-05	0.00033	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCC3—lung cancer	1.95e-05	0.000327	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AKR1C1—lung cancer	1.89e-05	0.000316	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—UGT1A1—lung cancer	1.84e-05	0.000307	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GNG11—lung cancer	1.77e-05	0.000296	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDOA—lung cancer	1.69e-05	0.000282	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NCOA3—lung cancer	1.64e-05	0.000274	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCG2—lung cancer	1.59e-05	0.000266	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ADCY1—lung cancer	1.59e-05	0.000266	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ENO2—lung cancer	1.56e-05	0.000261	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HPGDS—lung cancer	1.56e-05	0.000261	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.55e-05	0.000259	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTT1—lung cancer	1.51e-05	0.000253	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.5e-05	0.00025	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GCLC—lung cancer	1.5e-05	0.00025	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ENO1—lung cancer	1.42e-05	0.000237	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2E1—lung cancer	1.27e-05	0.000213	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NQO1—lung cancer	1.26e-05	0.00021	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—STK11—lung cancer	1.13e-05	0.00019	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTP1—lung cancer	1.05e-05	0.000176	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CAT—lung cancer	1.02e-05	0.000171	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCB1—lung cancer	9.93e-06	0.000166	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TYMS—lung cancer	9.75e-06	0.000163	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTM1—lung cancer	9.64e-06	0.000161	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP1A1—lung cancer	9.14e-06	0.000153	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ERCC2—lung cancer	9.07e-06	0.000152	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOA1—lung cancer	7.84e-06	0.000131	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CG—lung cancer	7.16e-06	0.00012	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—POMC—lung cancer	6.82e-06	0.000114	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CREBBP—lung cancer	6.64e-06	0.000111	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CD—lung cancer	6.29e-06	0.000105	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALB—lung cancer	6.21e-06	0.000104	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CB—lung cancer	5.49e-06	9.18e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTGS2—lung cancer	5.44e-06	9.09e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTEN—lung cancer	4.74e-06	7.93e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—EP300—lung cancer	4.52e-06	7.56e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CA—lung cancer	3.34e-06	5.6e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AKT1—lung cancer	2.73e-06	4.57e-05	CbGpPWpGaD
